EGFR in cancer: Signaling mechanisms, drugs, and acquired resistance
ML Uribe, I Marrocco, Y Yarden - Cancers, 2021 - mdpi.com
Simple Summary Growth factors are hormone-like molecules able to promote division and
migration of normal cells, but cancer captured the underlying mechanisms to unleash tumor …
migration of normal cells, but cancer captured the underlying mechanisms to unleash tumor …
Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics
M Adamaki, V Zoumpourlis - Pharmacology & therapeutics, 2021 - Elsevier
Prostate cancer (PCa) is one of the most commonly diagnosed malignancies and among the
leading causes of cancer-related death worldwide. It is a highly heterogeneous disease …
leading causes of cancer-related death worldwide. It is a highly heterogeneous disease …
GENT2: an updated gene expression database for normal and tumor tissues
Abstract Background Gene Expression database of Normal and Tumor tissues 2 (GENT2) is
an updated version of GENT, which has provided a user-friendly search platform for gene …
an updated version of GENT, which has provided a user-friendly search platform for gene …
Rethink of EGFR in cancer with its kinase independent function on board
R Thomas, Z Weihua - Frontiers in oncology, 2019 - frontiersin.org
The epidermal growth factor receptor (EGFR) is one of most potent oncogenes that are
commonly altered in cancers. As a receptor tyrosine kinase, EGFR's kinase activity has been …
commonly altered in cancers. As a receptor tyrosine kinase, EGFR's kinase activity has been …
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment
T Eguchi, C Sogawa, Y Okusha, K Uchibe, R Iinuma… - PLoS …, 2018 - journals.plos.org
Ability to form cellular aggregations such as tumorspheres and spheroids have been used
as a morphological marker of malignant cancer cells and in particular cancer stem cells …
as a morphological marker of malignant cancer cells and in particular cancer stem cells …
Androgen receptor-dependent mechanisms mediating drug resistance in prostate cancer
M Ehsani, FO David, A Baniahmad - Cancers, 2021 - mdpi.com
Simple Summary Prostate cancer can develop under hormone treatment and chemotherapy
from a castration-sensitive towards a castration-resistant into a drug resistant-tumor. The …
from a castration-sensitive towards a castration-resistant into a drug resistant-tumor. The …
3D porous chitosan-alginate scaffold stiffness promotes differential responses in prostate cancer cell lines
K Xu, K Ganapathy, T Andl, Z Wang, JA Copland… - Biomaterials, 2019 - Elsevier
Prostate cancer (PCa) is a leading cause of death for men worldwide. Most PCa patients die
from metastasis and bone is the most common metastatic site. Three dimensional (3D) …
from metastasis and bone is the most common metastatic site. Three dimensional (3D) …
Concise review: prostate cancer stem cells: current understanding
S Skvortsov, II Skvortsova, DG Tang, A Dubrovska - Stem Cells, 2018 - academic.oup.com
Prostate cancer (PCa) is heterogeneous, harboring phenotypically diverse cancer cell types.
PCa cell heterogeneity is caused by genomic instability that leads to the clonal competition …
PCa cell heterogeneity is caused by genomic instability that leads to the clonal competition …
Advances in exosome analysis
There is growing demand for novel biomarkers that detect early stage disease as well as
monitor clinical management and therapeutic strategies. Exosome analysis could provide …
monitor clinical management and therapeutic strategies. Exosome analysis could provide …
The contributions of prostate cancer stem cells in prostate cancer initiation and metastasis
Research in the last decade has clearly revealed a critical role of prostate cancer stem cells
(PCSCs) in prostate cancer (PC). Prostate stem cells (PSCs) reside in both basal and …
(PCSCs) in prostate cancer (PC). Prostate stem cells (PSCs) reside in both basal and …